John Gunn - Dodge & Cox
Holding/activity history for Neurocrine Biosciences, Inc. (NBIX)
← All NBIX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 5,461,037 | 0.40 | Reduce 0.85% | <0.01 | $122.14–142.82 · VW $132.92i | $719,437,014 | SEC |
| 2025 Q4 | 5,508,042 | 0.42 | Reduce 0.87% | <0.01 | $133.61–160.18 · VW $146.21i | $781,205,597 | SEC |
| 2025 Q3 | 5,556,618 | 0.42 | Reduce 0.18% | <0.01 | $123.67–148.00 · VW $135.30i | $780,038,035 | SEC |
| 2025 Q2 | 5,566,814 | 0.39 | Add 0.58% | <0.01 | $84.23–130.46 · VW $112.80i | $699,692,852 | SEC |
| 2025 Q1 | 5,534,624 | 0.35 | Add 83.48% | 0.16 | $105.18–154.61 · VW $127.56i | $612,129,414 | SEC |
| 2024 Q4 | 3,016,425 | 0.24 | Add 134.23% | 0.14 | $110.95–140.00 · VW $126.22i | $411,742,013 | SEC |
| 2024 Q3 | 1,287,820 | 0.08 | Add 0.55% | <0.01 | $114.08–157.98 · VW $131.56i | $148,382,620 | SEC |
| 2024 Q2 | 1,280,820 | 0.11 | Add 1.23% | <0.01 | $129.33–145.78 · VW $137.15i | $176,330,489 | SEC |
| 2024 Q1 | 1,265,244 | 0.10 | Add 0.44% | <0.01 | $128.00–148.37 · VW $136.63i | $174,502,452 | SEC |
| 2023 Q4 | 1,259,744 | 0.11 | Add 489.76% | 0.09 | $103.63–133.64 · VW $117.42i | $165,983,869 | SEC |
| 2023 Q3 | 213,602 | 0.02 | Buy | 0.02 | $93.28–119.29 · VW $106.42i | $24,030,225 | SEC |
Price snapshot:
Current price$174.10
Avg. buy price$122.89
+/- since buy41.67%
52-week low$122.14
52-week high$181.18